ID   SBDS_HUMAN              Reviewed;         250 AA.
AC   Q9Y3A5; A8K0P4; Q96FX0; Q9NV53;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 4.
DT   07-APR-2021, entry version 194.
DE   RecName: Full=Ribosome maturation protein SBDS;
DE   AltName: Full=Shwachman-Bodian-Diamond syndrome protein;
GN   Name=SBDS; ORFNames=CGI-97;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], VARIANTS SDS1 LYS-8; GLY-44; GLU-67; SER-87;
RP   THR-126 AND CYS-169, AND VARIANT THR-212.
RX   PubMed=12496757; DOI=10.1038/ng1062;
RA   Boocock G.R.B., Morrison J.A., Popovic M., Richards N., Ellis L.,
RA   Durie P.R., Rommens J.M.;
RT   "Mutations in SBDS are associated with Shwachman-Diamond syndrome.";
RL   Nat. Genet. 33:97-101(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=10810093; DOI=10.1101/gr.10.5.703;
RA   Lai C.-H., Chou C.-Y., Ch'ang L.-Y., Liu C.-S., Lin W.-C.;
RT   "Identification of novel human genes evolutionarily conserved in
RT   Caenorhabditis elegans by comparative proteomics.";
RL   Genome Res. 10:703-713(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain cortex, and Ovarian carcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=PNS;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 2-19, CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT
RP   SER-2, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Platelet;
RA   Bienvenut W.V., Claeys D.;
RL   Submitted (NOV-2005) to UniProtKB.
RN   [7]
RP   SUBCELLULAR LOCATION.
RX   PubMed=15860664; DOI=10.1182/blood-2005-02-0807;
RA   Austin K.M., Leary R.J., Shimamura A.;
RT   "The Shwachman-Diamond SBDS protein localizes to the nucleolus.";
RL   Blood 106:1253-1258(2005).
RN   [8]
RP   INTERACTION WITH NPM1 AND THE 60S RIBOSOMAL SUBUNIT, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=17475909; DOI=10.1182/blood-2007-02-075184;
RA   Ganapathi K.A., Austin K.M., Lee C.S., Dias A., Malsch M.M., Reed R.,
RA   Shimamura A.;
RT   "The human Shwachman-Diamond syndrome protein, SBDS, associates with
RT   ribosomal RNA.";
RL   Blood 110:1458-1465(2007).
RN   [9]
RP   FUNCTION, AND INTERACTION WITH NIP7.
RX   PubMed=17643419; DOI=10.1016/j.yexcr.2007.06.024;
RA   Hesling C., Oliveira C.C., Castilho B.A., Zanchin N.I.;
RT   "The Shwachman-Bodian-Diamond syndrome associated protein interacts with
RT   HsNip7 and its down-regulation affects gene expression at the
RT   transcriptional and translational levels.";
RL   Exp. Cell Res. 313:4180-4195(2007).
RN   [10]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH RPA1; PRKDC AND THE
RP   60S RIBOSOME SUBUNIT.
RX   PubMed=19602484; DOI=10.1093/hmg/ddp316;
RA   Ball H.L., Zhang B., Riches J.J., Gandhi R., Li J., Rommens J.M.,
RA   Myers J.S.;
RT   "Shwachman-Bodian Diamond syndrome is a multi-functional protein implicated
RT   in cellular stress responses.";
RL   Hum. Mol. Genet. 18:3684-3695(2009).
RN   [11]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=19759903; DOI=10.1371/journal.pone.0007084;
RA   Orelio C., Verkuijlen P., Geissler J., van den Berg T.K., Kuijpers T.W.;
RT   "SBDS expression and localization at the mitotic spindle in human myeloid
RT   progenitors.";
RL   PLoS ONE 4:E7084-E7084(2009).
RN   [12]
RP   INTERACTION WITH CLN3.
RX   PubMed=20015955; DOI=10.1093/hmg/ddp560;
RA   Vitiello S.P., Benedict J.W., Padilla-Lopez S., Pearce D.A.;
RT   "Interaction between Sdo1p and Btn1p in the Saccharomyces cerevisiae model
RT   for Batten disease.";
RL   Hum. Mol. Genet. 19:931-942(2010).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.m111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [17]
RP   INTERACTION WITH EFL1.
RX   PubMed=25991726; DOI=10.1074/jbc.m114.626275;
RA   Garcia-Marquez A., Gijsbers A., de la Mora E., Sanchez-Puig N.;
RT   "Defective guanine nucleotide exchange in the elongation factor-like 1
RT   (EFL1) GTPase by mutations in the Shwachman-Diamond syndrome protein.";
RL   J. Biol. Chem. 290:17669-17678(2015).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [19]
RP   STRUCTURE BY NMR, AND RNA-BINDING.
RX   PubMed=20053358; DOI=10.1016/j.jmb.2009.12.039;
RA   de Oliveira J.F., Sforca M.L., Blumenschein T.M., Goldfeder M.B.,
RA   Guimaraes B.G., Oliveira C.C., Zanchin N.I., Zeri A.C.;
RT   "Structure, dynamics, and RNA interaction analysis of the human SBDS
RT   protein.";
RL   J. Mol. Biol. 396:1053-1069(2010).
RN   [20]
RP   STRUCTURE BY NMR, FUNCTION, CHARACTERIZATION OF VARIANT SDS1 THR-126, AND
RP   MUTAGENESIS OF LYS-151.
RX   PubMed=21536732; DOI=10.1101/gad.623011;
RA   Finch A.J., Hilcenko C., Basse N., Drynan L.F., Goyenechea B., Menne T.F.,
RA   Gonzalez Fernandez A., Simpson P., D'Santos C.S., Arends M.J., Donadieu J.,
RA   Bellanne-Chantelot C., Costanzo M., Boone C., McKenzie A.N., Freund S.M.,
RA   Warren A.J.;
RT   "Uncoupling of GTP hydrolysis from eIF6 release on the ribosome causes
RT   Shwachman-Diamond syndrome.";
RL   Genes Dev. 25:917-929(2011).
RN   [21]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.30 ANGSTROMS), AND IDENTIFICATION IN A
RP   COMPLEX WITH SBDS; 60S RIBOSOMAL SUBUNIT AND EFL1.
RX   PubMed=26479198; DOI=10.1038/nsmb.3112;
RA   Weis F., Giudice E., Churcher M., Jin L., Hilcenko C., Wong C.C.,
RA   Traynor D., Kay R.R., Warren A.J.;
RT   "Mechanism of eIF6 release from the nascent 60S ribosomal subunit.";
RL   Nat. Struct. Mol. Biol. 22:914-919(2015).
RN   [22]
RP   VARIANT SDS1 THR-33.
RX   PubMed=24898207; DOI=10.1186/1471-2350-15-64;
RA   Carvalho C.M., Zuccherato L.W., Williams C.L., Neill N.J., Murdock D.R.,
RA   Bainbridge M., Jhangiani S.N., Muzny D.M., Gibbs R.A., Ip W.,
RA   Guillerman R.P., Lupski J.R., Bertuch A.A.;
RT   "Structural variation and missense mutation in SBDS associated with
RT   Shwachman-Diamond syndrome.";
RL   BMC Med. Genet. 15:64-64(2014).
CC   -!- FUNCTION: Required for the assembly of mature ribosomes and ribosome
CC       biogenesis. Together with EFL1, triggers the GTP-dependent release of
CC       EIF6 from 60S pre-ribosomes in the cytoplasm, thereby activating
CC       ribosomes for translation competence by allowing 80S ribosome assembly
CC       and facilitating EIF6 recycling to the nucleus, where it is required
CC       for 60S rRNA processing and nuclear export. Required for normal levels
CC       of protein synthesis. May play a role in cellular stress resistance.
CC       May play a role in cellular response to DNA damage. May play a role in
CC       cell proliferation. {ECO:0000269|PubMed:17643419,
CC       ECO:0000269|PubMed:19602484, ECO:0000269|PubMed:19759903,
CC       ECO:0000269|PubMed:21536732}.
CC   -!- SUBUNIT: Associates with the 60S ribosomal subunit. Interacts with
CC       NPM1, RPA1 and PRKDC. May interact with NIP7 (PubMed:17643419). Found
CC       in a complex consisting of the 60S ribosomal subunit, SBDS and EFL1
CC       (PubMed:26479198). Interacts with EFL1 (PubMed:25991726). Interacts
CC       with CLN3 (PubMed:20015955). {ECO:0000269|PubMed:17475909,
CC       ECO:0000269|PubMed:17643419, ECO:0000269|PubMed:19602484,
CC       ECO:0000269|PubMed:20015955, ECO:0000269|PubMed:25991726,
CC       ECO:0000269|PubMed:26479198}.
CC   -!- INTERACTION:
CC       Q9Y3A5; Q96AP0: ACD; NbExp=2; IntAct=EBI-1046471, EBI-717666;
CC       Q9Y3A5; Q8WZ60: KLHL6; NbExp=3; IntAct=EBI-1046471, EBI-6426464;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus, nucleolus. Nucleus,
CC       nucleoplasm. Cytoplasm, cytoskeleton, spindle. Note=Primarily detected
CC       in the cytoplasm, and at low levels in nucleus and nucleolus
CC       (PubMed:19602484 and PubMed:17475909). Detected in the nucleolus during
CC       G1 and G2 phase of the cell cycle, and diffusely distributed in the
CC       nucleus during S phase. Detected at the mitotic spindle. Colocalizes
CC       with the microtubule organizing center during interphase
CC       (PubMed:19759903). {ECO:0000269|PubMed:19759903}.
CC   -!- TISSUE SPECIFICITY: Widely expressed.
CC   -!- DISEASE: Shwachman-Diamond syndrome 1 (SDS1) [MIM:260400]: A form of
CC       Shwachman-Diamond syndrome, a disorder characterized by hematopoietic
CC       abnormalities, exocrine pancreatic dysfunction, and skeletal dysplasia.
CC       Intermittent or chronic neutropenia is the most common hematological
CC       manifestation, followed by anemia and thrombocytopenia. Some patients
CC       progress to bone marrow failure, myelodysplastic syndrome and malignant
CC       transformation, with acute myelogenous leukemia being the most common.
CC       Exocrine pancreatic dysfunction is generally the first presenting
CC       symptom in infancy. Short stature and metaphyseal dysplasia are the
CC       most frequent skeletal manifestations. SDS1 inheritance is autosomal
CC       recessive. {ECO:0000269|PubMed:12496757, ECO:0000269|PubMed:21536732,
CC       ECO:0000269|PubMed:24898207}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the SDO1/SBDS family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=SBDSbase; Note=SBDS mutation db;
CC       URL="http://structure.bmc.lu.se/idbase/SBDSbase/";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY169963; AAN77490.1; -; mRNA.
DR   EMBL; AF151855; AAD34092.1; -; mRNA.
DR   EMBL; AK001779; BAA91905.1; -; mRNA.
DR   EMBL; AK289609; BAF82298.1; -; mRNA.
DR   EMBL; CH471140; EAX07906.1; -; Genomic_DNA.
DR   EMBL; BC065700; AAH65700.1; -; mRNA.
DR   CCDS; CCDS5537.1; -.
DR   RefSeq; NP_057122.2; NM_016038.3.
DR   PDB; 2KDO; NMR; -; A=1-250.
DR   PDB; 2L9N; NMR; -; A=1-250.
DR   PDB; 5AN9; EM; 3.30 A; J=1-250.
DR   PDB; 5ANB; EM; 4.10 A; J=1-250.
DR   PDB; 5ANC; EM; 4.20 A; J=1-250.
DR   PDB; 6QKL; EM; 3.30 A; J=1-250.
DR   PDBsum; 2KDO; -.
DR   PDBsum; 2L9N; -.
DR   PDBsum; 5AN9; -.
DR   PDBsum; 5ANB; -.
DR   PDBsum; 5ANC; -.
DR   PDBsum; 6QKL; -.
DR   BMRB; Q9Y3A5; -.
DR   SMR; Q9Y3A5; -.
DR   BioGRID; 119307; 73.
DR   IntAct; Q9Y3A5; 16.
DR   STRING; 9606.ENSP00000246868; -.
DR   iPTMnet; Q9Y3A5; -.
DR   PhosphoSitePlus; Q9Y3A5; -.
DR   BioMuta; SBDS; -.
DR   DMDM; 28380824; -.
DR   EPD; Q9Y3A5; -.
DR   jPOST; Q9Y3A5; -.
DR   MassIVE; Q9Y3A5; -.
DR   MaxQB; Q9Y3A5; -.
DR   PaxDb; Q9Y3A5; -.
DR   PeptideAtlas; Q9Y3A5; -.
DR   PRIDE; Q9Y3A5; -.
DR   ProteomicsDB; 85997; -.
DR   Antibodypedia; 14141; 232 antibodies.
DR   DNASU; 51119; -.
DR   Ensembl; ENST00000246868; ENSP00000246868; ENSG00000126524.
DR   GeneID; 51119; -.
DR   KEGG; hsa:51119; -.
DR   UCSC; uc003tvm.2; human.
DR   CTD; 51119; -.
DR   DisGeNET; 51119; -.
DR   GeneCards; SBDS; -.
DR   GeneReviews; SBDS; -.
DR   HGNC; HGNC:19440; SBDS.
DR   HPA; ENSG00000126524; Low tissue specificity.
DR   MalaCards; SBDS; -.
DR   MIM; 260400; phenotype.
DR   MIM; 607444; gene.
DR   neXtProt; NX_Q9Y3A5; -.
DR   OpenTargets; ENSG00000126524; -.
DR   Orphanet; 88; Idiopathic aplastic anemia.
DR   Orphanet; 811; Shwachman-Diamond syndrome.
DR   PharmGKB; PA134978742; -.
DR   VEuPathDB; HostDB:ENSG00000126524.9; -.
DR   eggNOG; KOG2917; Eukaryota.
DR   GeneTree; ENSGT00390000008135; -.
DR   HOGENOM; HOG000216685; -.
DR   InParanoid; Q9Y3A5; -.
DR   OMA; WEVVGFV; -.
DR   OrthoDB; 1217666at2759; -.
DR   PhylomeDB; Q9Y3A5; -.
DR   TreeFam; TF300881; -.
DR   PathwayCommons; Q9Y3A5; -.
DR   SIGNOR; Q9Y3A5; -.
DR   BioGRID-ORCS; 51119; 728 hits in 977 CRISPR screens.
DR   ChiTaRS; SBDS; human.
DR   EvolutionaryTrace; Q9Y3A5; -.
DR   GeneWiki; SBDS; -.
DR   GenomeRNAi; 51119; -.
DR   Pharos; Q9Y3A5; Tbio.
DR   PRO; PR:Q9Y3A5; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   RNAct; Q9Y3A5; protein.
DR   Bgee; ENSG00000126524; Expressed in tibial artery and 120 other tissues.
DR   ExpressionAtlas; Q9Y3A5; baseline and differential.
DR   Genevisible; Q9Y3A5; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005730; C:nucleolus; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0000922; C:spindle pole; IDA:UniProtKB.
DR   GO; GO:0008017; F:microtubule binding; IDA:UniProtKB.
DR   GO; GO:0043022; F:ribosome binding; IDA:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0019843; F:rRNA binding; IDA:UniProtKB.
DR   GO; GO:0048539; P:bone marrow development; IMP:UniProtKB.
DR   GO; GO:0030282; P:bone mineralization; IMP:UniProtKB.
DR   GO; GO:0002244; P:hematopoietic progenitor cell differentiation; IMP:UniProtKB.
DR   GO; GO:0001833; P:inner cell mass cell proliferation; IEA:Ensembl.
DR   GO; GO:0030595; P:leukocyte chemotaxis; IDA:UniProtKB.
DR   GO; GO:0042256; P:mature ribosome assembly; IDA:UniProtKB.
DR   GO; GO:0007052; P:mitotic spindle organization; IDA:UniProtKB.
DR   GO; GO:0006364; P:rRNA processing; IMP:UniProtKB.
DR   Gene3D; 1.10.10.900; -; 1.
DR   Gene3D; 3.30.1250.10; -; 1.
DR   InterPro; IPR018978; Ribosome_mat_SBDS_C.
DR   InterPro; IPR018023; Ribosome_mat_SBDS_CS.
DR   InterPro; IPR019783; Ribosome_mat_SBDS_N.
DR   InterPro; IPR036786; Ribosome_mat_SBDS_N_sf.
DR   InterPro; IPR002140; Sdo1/SBDS.
DR   InterPro; IPR039100; Sdo1/SBDS-like.
DR   InterPro; IPR037188; Sdo1/SBDS_central_sf.
DR   PANTHER; PTHR10927; PTHR10927; 1.
DR   Pfam; PF01172; SBDS; 1.
DR   Pfam; PF09377; SBDS_C; 1.
DR   SUPFAM; SSF109728; SSF109728; 1.
DR   SUPFAM; SSF89895; SSF89895; 1.
DR   TIGRFAMs; TIGR00291; RNA_SBDS; 1.
DR   PROSITE; PS01267; UPF0023; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Cytoplasm; Cytoskeleton;
KW   Direct protein sequencing; Disease variant; Nucleus; Reference proteome;
KW   Ribosome biogenesis.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|Ref.6, ECO:0007744|PubMed:22223895,
FT                   ECO:0007744|PubMed:22814378"
FT   CHAIN           2..250
FT                   /note="Ribosome maturation protein SBDS"
FT                   /id="PRO_0000123762"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000269|Ref.6, ECO:0007744|PubMed:22223895,
FT                   ECO:0007744|PubMed:22814378"
FT   VARIANT         8
FT                   /note="N -> K (in SDS1; unknown pathological significance;
FT                   dbSNP:rs28942099)"
FT                   /evidence="ECO:0000269|PubMed:12496757"
FT                   /id="VAR_015390"
FT   VARIANT         33
FT                   /note="K -> T (in SDS1; dbSNP:rs373730800)"
FT                   /evidence="ECO:0000269|PubMed:24898207"
FT                   /id="VAR_071673"
FT   VARIANT         44
FT                   /note="E -> G (in SDS1; unknown pathological significance;
FT                   dbSNP:rs1554341516)"
FT                   /evidence="ECO:0000269|PubMed:12496757"
FT                   /id="VAR_015391"
FT   VARIANT         67
FT                   /note="K -> E (in SDS1; unknown pathological significance;
FT                   dbSNP:rs1554341499)"
FT                   /evidence="ECO:0000269|PubMed:12496757"
FT                   /id="VAR_015392"
FT   VARIANT         87
FT                   /note="I -> S (in SDS1; unknown pathological significance;
FT                   dbSNP:rs1554341363)"
FT                   /evidence="ECO:0000269|PubMed:12496757"
FT                   /id="VAR_015393"
FT   VARIANT         126
FT                   /note="R -> T (in SDS1; strongly reduced release of EIF6
FT                   from pre-60S ribosome subunits; dbSNP:rs113993995)"
FT                   /evidence="ECO:0000269|PubMed:12496757,
FT                   ECO:0000269|PubMed:21536732"
FT                   /id="VAR_015394"
FT   VARIANT         169
FT                   /note="R -> C (in SDS1; unknown pathological significance;
FT                   dbSNP:rs113993996)"
FT                   /evidence="ECO:0000269|PubMed:12496757"
FT                   /id="VAR_015395"
FT   VARIANT         212
FT                   /note="I -> T (in dbSNP:rs79344818)"
FT                   /evidence="ECO:0000269|PubMed:12496757"
FT                   /id="VAR_015396"
FT   MUTAGEN         151
FT                   /note="K->N: Strongly reduced release of EIF6 from pre-60S
FT                   ribosome subunits."
FT                   /evidence="ECO:0000269|PubMed:21536732"
FT   CONFLICT        41..43
FT                   /note="SGV -> RAW (in Ref. 2; AAD34092)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        89
FT                   /note="T -> A (in Ref. 2; AAD34092)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        105
FT                   /note="E -> G (in Ref. 2; AAD34092)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        114
FT                   /note="I -> F (in Ref. 2; AAD34092)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        126
FT                   /note="R -> G (in Ref. 2; AAD34092)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        143
FT                   /note="S -> L (in Ref. 2; AAD34092)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        146
FT                   /note="T -> P (in Ref. 2; AAD34092)"
FT                   /evidence="ECO:0000305"
FT   TURN            6..8
FT                   /evidence="ECO:0007744|PDB:2L9N"
FT   STRAND          15..21
FT                   /evidence="ECO:0007744|PDB:5AN9"
FT   STRAND          26..31
FT                   /evidence="ECO:0007744|PDB:5AN9"
FT   HELIX           35..41
FT                   /evidence="ECO:0007744|PDB:5AN9"
FT   HELIX           46..50
FT                   /evidence="ECO:0007744|PDB:5AN9"
FT   STRAND          51..55
FT                   /evidence="ECO:0007744|PDB:2L9N"
FT   STRAND          57..59
FT                   /evidence="ECO:0007744|PDB:5AN9"
FT   TURN            60..63
FT                   /evidence="ECO:0007744|PDB:5AN9"
FT   STRAND          64..66
FT                   /evidence="ECO:0007744|PDB:2KDO"
FT   HELIX           68..75
FT                   /evidence="ECO:0007744|PDB:5AN9"
FT   HELIX           80..90
FT                   /evidence="ECO:0007744|PDB:5AN9"
FT   STRAND          91..94
FT                   /evidence="ECO:0007744|PDB:5AN9"
FT   HELIX           97..115
FT                   /evidence="ECO:0007744|PDB:5AN9"
FT   STRAND          116..118
FT                   /evidence="ECO:0007744|PDB:5AN9"
FT   STRAND          122..124
FT                   /evidence="ECO:0007744|PDB:5AN9"
FT   HELIX           130..140
FT                   /evidence="ECO:0007744|PDB:5AN9"
FT   STRAND          146..148
FT                   /evidence="ECO:0007744|PDB:5AN9"
FT   HELIX           150..164
FT                   /evidence="ECO:0007744|PDB:5AN9"
FT   STRAND          170..178
FT                   /evidence="ECO:0007744|PDB:5AN9"
FT   TURN            180..182
FT                   /evidence="ECO:0007744|PDB:5AN9"
FT   HELIX           183..193
FT                   /evidence="ECO:0007744|PDB:5AN9"
FT   STRAND          194..200
FT                   /evidence="ECO:0007744|PDB:5AN9"
FT   STRAND          203..205
FT                   /evidence="ECO:0007744|PDB:5AN9"
FT   STRAND          207..214
FT                   /evidence="ECO:0007744|PDB:5AN9"
FT   TURN            215..217
FT                   /evidence="ECO:0007744|PDB:2L9N"
FT   HELIX           218..229
FT                   /evidence="ECO:0007744|PDB:5AN9"
FT   STRAND          234..248
FT                   /evidence="ECO:0007744|PDB:5AN9"
SQ   SEQUENCE   250 AA;  28764 MW;  D35C43003C05F5A7 CRC64;
     MSIFTPTNQI RLTNVAVVRM KRAGKRFEIA CYKNKVVGWR SGVEKDLDEV LQTHSVFVNV
     SKGQVAKKED LISAFGTDDQ TEICKQILTK GEVQVSDKER HTQLEQMFRD IATIVADKCV
     NPETKRPYTV ILIERAMKDI HYSVKTNKST KQQALEVIKQ LKEKMKIERA HMRLRFILPV
     NEGKKLKEKL KPLIKVIESE DYGQQLEIVC LIDPGCFREI DELIKKETKG KGSLEVLNLK
     DVEEGDEKFE
//
